Skip to main content
An official website of the United States government

Brain Malignancies Steering Committee

The NCI Brain Malignancies Steering Committee (BMSC) was established in November 2010. It addresses the design, prioritization, and evaluation of concepts for large phase 2 and phase 3 clinical trials in adult brain cancers and all pediatric brain cancer trials. View the BMSC roster.

Strategic Priorities

  • BMSC Strategic Priorities were formulated with the goal that the majority of submitted concepts would align with these established priorities. They address areas of unmet clinical need, important unanswered clinical questions, and potential new approaches to disease treatment.

Clinical Trials Planning Meetings (CTPMs)

CTPMs are held periodically and focus on specific clinical trial related topics. The following are important BMSC CTPMs:


For more information, contact NCI CCCT Program Director, Abdul Tawab Amiri, Ph.D., at